Abstract:Background: Aconitum alkaloids from Aconitum species are often used to treat arthritis and rheumatic diseases but have the drawback of high toxicity. Identifying their pharmacokinetic behaviour is important for the safe clinical application of Aconitum species. Efflux transporters (ETs), including P-glycoprotein (P-gp), multidrug resistance-associated protein 2 (MRP2), and breast cancer resistance protein (BCRP), have important functions in regulating the pharmacokinetic behaviours of drugs and in herb-herb or herb-drug interactions (HDIs). The Aconitum alkaloids regulate P-gp expression and function, but their effects on MRP2 and BCRP expression remain unknown. Purpose: To determine the effects of three Aconitum alkaloids, aconitine (AC), benzoylaconine (BAC), and aconine, on MRP2 and BCRP. Methods: The levels of the protein and mRNA expression of MRP2 and BCRP in vivo and in vitro were measured via Western blotting and real-time PCR, respectively. Fluorescence signals of MRP2 and BCRP were detected via confocal fluorescence microscopy. A reporter assay using HepG2-C8 cells, which were generated by transfecting plasmids containing the antioxidant response element (ARE)-luciferin gene into HepG2 cells, was used to examine the ARE-luciferin activity. The transport activities of MRP2 and BCRP were tested via flow cytometry using substrate probes. Results: The Aconitum alkaloids significantly up-regulated MRP2 and BCRP expression, accompanied by a marked increase in nuclear factor E2-related factor-2 (Nrf2) expression in the jejunum, ileum, and colon of FVB mice, in the order AC < BAC < aconine. In the in vitro model, the Aconitum alkaloids increased MRP2 and BCRP expression in Caco-2 and LS174T cells, in the order AC < BAC < aconine. Additionally, these alkaloids promoted the translocation of Nrf2 from the cytoplasm to the nucleus and significantly increased ARE-luciferin activity in HepG2-C8 cells. Luteolin, a potent inhibitor of Nrf2, markedly prevented MRP2 and BCRP expression from being induced by the three Aconitum alkaloids. The efflux activity of MRP2 was also significantly increased in cells receiving the same treatment. Conclusions: The tested Aconitum alkaloids significantly increased the expression of MRP2 and BCRP by activating the Nrf2-mediated signalling pathway and enhanced the efflux activity of MRP2. The potential for herb-herb interactions or HDIs exists when Aconitum species are co-administered with substrate drugs that are transported via MRP2 and BCRP. Therefore, the Aconitum alkaloids may be used as quality indicators for the herbs of Aconitum species.

Mdr1a, Bcrp and Mrp2 regulate the efficacy and toxicity of mesaconitine and hypaconitine by altering their tissue accumulation and in vivo residence

m<SUP>6</SUP>A demethylase ALKBH5 attenuates doxorubicin-induced cardiotoxicity via posttranscriptional stabilization of Rasal3

A proton-coupled organic cation antiporter is involved in the blood-brain barrier transport of Aconitum alkaloids

Study on the Mechanism of Mesaconitine-Induced Hepatotoxicity in Rats Based on Metabonomics and Toxicology Network

Aconitum alkaloids, the major components of Aconitum species, affect expression of multidrug resistance-associated protein 2 and breast cancer resistance protein by activating the Nrf2-mediated signalling pathway

Involvement of autophagy in mesaconitine-induced neurotoxicity in HT22 cells revealed through integrated transcriptomic, proteomic, and m6A epitranscriptomic profiling

Absorption and Metabolism of Three Monoester-Diterpenoid Alkaloids in Aconitum Carmichaeli after Oral Administration to Rats by Hplc-Ms

[Effect of Concanavalin A on Expression of MAPEG Mrna in Balb/c Mouse Brain].

Inhibition of the INa/K and the activation of peak INa contribute to the arrhythmogenic effects of aconitine and mesaconitine in guinea pigs

Intestinal Transport of Pure Diester-type Alkaloids from an Aconite Extract Across the Caco-2 Cell Monolayer Model

Role of Μ-Δ Heterodimer in Down-Regulation of Expression of Excitatory Amino Acid Transporter 3 in Hippocampi Caused by Reinstatement of Morphine-Induced Conditioned Place Preference in Rats

Human Intestine and Liver Microsomal Metabolic Differences Between C19-diester and Monoester Diterpenoid Alkaloids from the Roots of Aconitum Carmichaelii Debx.

Multidrug resistance associated proteins as determining factors of pharmacokinetics and pharmacodynamics of drugs.

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

Integrated Virtual Screening and in Vitro Studies for Exploring the Mechanism of Triterpenoids in Chebulae Fructus Alleviating Mesaconitine-Induced Cardiotoxicity Via TRPV1 Channel

Roles of P-glycoprotein and Multidrug Resistance Protein in Transporting Para-Aminosalicylic Acid and Its N -Acetylated Metabolite in Mice Brain

Role of P-glycoprotein in Regulating the Efficacy, Toxicity and Pharmacokinetics of Yunaconitine

Neuropharmacological Effects of Mesaconitine: Evidence from Molecular and Cellular Basis of Neural Circuit

Elevated MAOA Impairs Intracellular Β 1 ‐adrenegic Signaling and Myocardial Contractility in Heart Failure

Abstract P1066: Monoamine Oxidase A And Organic Cation Transporter 3 Coordinate Intracellular Adrenergic Signaling To Calibrate Cardiac Function

Metabolomic Analysis of Biofluids from Rats Treated with Aconitum Alkaloids Using Nuclear Magnetic Resonance and Gas Chromatography/time-of-flight Mass Spectrometry.